tiprankstipranks
JCR Pharmaceuticals Co., Ltd. (JP:4552)
:4552
Japanese Market
4552
JCR Pharmaceuticals Co., Ltd.
RESEARCH TOOLSreports
Want to see JP:4552 full AI Analyst Report?

JCR Pharmaceuticals Co., Ltd. (4552) Income Statement

1 Followers

JCR Pharmaceuticals Co., Ltd. Income Statement

Last quarter (Q4 2025), JCR Pharmaceuticals Co., Ltd.'s total revenue was ¥7.19B, a decrease of -16.07% from the same quarter last year. In Q4, JCR Pharmaceuticals Co., Ltd.'s net income was ¥-4.18B. See JCR Pharmaceuticals Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 26Mar 25Mar 24Mar 23
Total Revenue
¥ 33.07B¥ 40.32B¥ 42.87B¥ 34.34B¥ 51.08B
Gross Profit
¥ 21.55B¥ 30.06B¥ 31.25B¥ 25.46B¥ 40.62B
Operating Expenses
¥ 28.39B¥ 29.63B¥ 23.72B¥ 20.48B¥ 20.69B
Depreciation and Amortization
¥ 3.37B¥ 2.56B¥ 3.20B¥ 2.00B¥ 1.95B
EBITDA
¥ -3.47B¥ 2.99B¥ 10.73B¥ 6.97B¥ 21.88B
Operating Income
¥ -6.84B¥ 431.00M¥ 7.53B¥ 4.98B¥ 19.93B
Other Income/Expenses
¥ 427.00M¥ 2.79B¥ -288.00M¥ 435.00M¥ -531.00M
Pretax Income
¥ -6.41B¥ 3.22B¥ 7.24B¥ 5.41B¥ 19.40B
Net Income
¥ -4.76B¥ 2.18B¥ 5.51B¥ 3.77B¥ 14.51B
Per Share Metrics
Basic EPS
¥ -38.43¥ 17.86¥ 44.13¥ 30.34¥ 117.26
Diluted EPS
¥ -38.43¥ 17.85¥ 43.92¥ 30.22¥ 116.79
Weighted Average Shares Outstanding
 123.83M 121.94M 124.79M 124.31M 123.72M
Weighted Average Shares Outstanding (Diluted)
 123.83M 122.01M 125.40M 124.84M 124.21M
Currency in JPY

JCR Pharmaceuticals Co., Ltd. Earnings and Revenue History